Overview Single Dose Study of BMS-820836 Status: Completed Trial end date: 2009-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the safety and tolerability of BMS-820836 after single doses Phase: Phase 1 Details Lead Sponsor: Bristol-Myers Squibb